Glen Tullman

By Jonah Comstock April 7, 2015
Livongo Health, the diabetes management company launched last fall by former Allscripts CEO Glen Tullman, has raised $20 million in second-round funding. Kleiner Perkins Caufield & Byers (KPCB) and DFJ Venture contributed to the round, as did previous investor General Catalyst Partners. "With thousands of people now using Livongo for Diabetes, it's clear that the best way for people to...
By Jonah Comstock September 25, 2014
There’s no question that funding for digital health companies is high -- a recent report from Accenture predicted funding for digital health startups will reach $6.5 billion by the end of 2017, up from $3.5 billion in 2014. But that doesn’t mean it’s smooth sailing for digital health investors or the companies seeking funding. At a Tuesday session at Health 2.0 in Santa Clara, California, a panel...
By Jonah Comstock September 10, 2014
Glen Tullman, the former Allscripts CEO who left the company at the end of 2012 by mutual agreement, is back in the health field. His newest venture, Livongo, launched from the stage of TechCrunch's Disrupt conference in San Francisco and has already raised a $10 million funding round from General Catalyst Partners. "Our plan is to use the experience gained in Silicon Valley on consumer ...
By Jonah Comstock March 28, 2014
Mountain View, California-based TrueVault has raised $2.5 million in seed funding according to TechCrunch, from a range of big name investors including FundersClub, Paul Buchheit, ScoreBig founder Joel Milne, and an LLC that includes Andreessen Horowitz, General Catalyst, Maverick, and Khosla Ventures, and Immunity Project founders Reid Rubsamen, Naveen Jain, and Ian Cinnamon. The company, which...
By Neil Versel May 6, 2013
Former Allscripts Healthcare Solutions CEO Glen Tullman confirms to MobiHealthNews what has been rumored for weeks: He is working on a mobile health startup through his 7Wire Ventures investment vehicle. While he won't fully tip his hand now, Tullman says he is involved in a venture that will help mobilize treatment of chronic diseases both from the consumer side and for the purpose of population...

Editor's Pick